ArticlebioRxiv : the preprint server for biology2024

FDA-approved PDE4 inhibitors reduce the dominant toxicity of ALS-FTD-associated

Swati Maitra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.